US panel gives nod to Merck hepatitis C drug

April 27, 2011 by Kerry Sheridan

A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.

The advisory committee agreed by a vote of 18-0 that available data supports "approval of boceprevir for treatment of patients with chronic hepatitis C genotype 1 in combination with pegylated interferon and ribavirin."

The FDA does not have to follow the recommendations of its advisory panel but it often does.

Boceprevir, an investigational drug being marketed under the name Victrelis, is a protease inhibitor, and works in combination with the current two-drug regimen to stop the hepatitis C virus from replicating.

A study last month in the New England Journal of Medicine showed that among two groups of patients who took the three-drug combination, 59 percent and 66 percent got rid of the virus compared to 21 percent in the control group taking the two drugs only.

"This drug is going to exponentially improve the outcomes of people with hepatitis C," said panel member Patrick Clay after the vote.

There is currently no vaccine for the hepatitis C virus, and the Centers for Disease Control and Prevention estimates that more than 12,000 people die each year of liver disease and liver cancer associated with the illness.

Most people infected with hepatitis C live symptom-free for years, but once it is discovered it is often too late for it to respond to the current two-drug treatment.

In the past the disease could be spread through contact with infected blood products, and is still contracted by drug users sharing needles or straws during the use of cocaine, or by unprotected sex with a sufferer.

"The positive recommendation brings us one step closer to bringing Victrelis to men and women who need it, and reinforces our ongoing commitment to developing innovative therapies to treat chronic hepatitis C," said a statement by Peter Kim, president, Merck Research Laboratories.

"We're pleased with the panel's decision and look forward to working with the FDA as it continues to evaluate the application for Victrelis."

Another drug, telaprevir, is a hepatitis C virus protease inhibitor manufactured by Vertex Pharmaceuticals in Massachusetts, and will be voted on Thursday by the same FDA advisory panel.

Telaprevir has also shown promise in peer-reviewed studies.

However, some experts have expressed concern about the complexity of the three-pill regime and the potential for bad drug interactions.

"I have significant concerns about the unknown drug interactions which I think will have potentially big implications," said panel member Michelle Roland at the Wednesday vote on boceprevir.

She urged more "drug interaction studies as soon as possible."

(c) 2011 AFP


Rank 5 /5 (1 vote)
Relevant PhysicsForums posts
  • Potential Breakthrough in Seizure Control
    createdMay 26, 2012
  • Popping/Cracked sternum.
    createdMay 25, 2012
  • Which Mental Illness Encompasses This Problem?
    createdMay 25, 2012
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Keep food safety in mind this memorial day weekend

(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.

Medicine & Health / Health

created 10 hours ago | popularity not rated yet | comments 0

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Medicine & Health / Alzheimer's disease & dementia

created 19 hours ago | popularity not rated yet | comments 0

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Medicine & Health / Other

created 20 hours ago | popularity not rated yet | comments 0

Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Medicine & Health / Inflammatory disorders

created 20 hours ago | popularity not rated yet | comments 1 | with audio podcast

Weight struggles? Blame new neurons in your hypothalamus

New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...

Medicine & Health / Neuroscience

created May 21, 2012 | popularity 5 / 5 (1) | comments 6 | with audio podcast


Scientist: Evolution debate will soon be history

(AP) -- Richard Leakey predicts skepticism over evolution will soon be history. Not that the avowed atheist has any doubts himself.

Dell tablet leak: 10.1-inch display, two-battery choice

(Phys.org) -- Headline after headline talks about vendors’ tablets in the wings as likely number-one contenders for the iPad. Such claims have justifiably been taken with a grain of salt, considering ...

SpotterRF debuts Radar Backpack Kit (w/ Video)

(Phys.org) -- SpotterRF has announced a special radar backpack kit designed to enhance situational awareness for soldiers on the ground. The company says its special radar is designed for warfighters as part ...

SpaceX capsule has 'new car' smell, astronauts say (Update)

SpaceX's Dragon cargo vessel smells like a new car, said astronauts at the International Space Station after opening the hatches Saturday following the spacecraft's landmark mission to the orbiting lab.

Thousands of shellfish found dead in Peru

Thousands of crustaceans were found dead off the coast of Lima following the mystery mass death of dolphins and pelicans, the Peruvian Navy said Friday.

Astronomers seize last chance in lifetime for Venus Transit

Astronomers are gearing for one the rarest events in the Solar System: an alignment of Earth, Venus and the Sun that will not be seen for another 105 years.